Skip to content
DraconiticResearch
Search Sources API
194,161 studies31 sourcesUpdated 15 min ago
Peer-reviewedCC BYJournal of microbiology and biotechnology

A New Simplified Coralmycin Derivative with Potent Anti-Gram-Negative Activity and Its Congeners Produced by the Myxobacterium Corallococcus coralloides M23.

  1. 1Infectious Disease Research Center, Korea Research Institute of Bioscience and Biotechnology, Yusong, Daejeon 305-806, Republic of Korea.

Abstract

Multidrug-resistant (MDR) Gram-negative bacterial infections urgently require new antibacterial agents with novel chemical scaffolds. In our continued investigation of minor metabolites produced by the myxobacterium Corallococcus coralloides M23, we isolated three new coralmycin derivatives, coralmycins J (1), K (2), and L (3), from large-scale fermentation cultures. Spectroscopic analyses revealed that these compounds represent structurally simplified derivatives of coralmycin with varying degrees of truncation. Compounds 1-4 (coralmycins J, K, L, and A) are new natural products isolated in our recent and current studies, while compound 5 (cystobactamid 919-2) is the externally reported reference compound used for comparison. Compound 1 exhibited potent antibacterial activity against both Gram-positive and Gram-negative bacteria and effectively inhibited E. coli DNA gyrase, whereas compounds 2 and 3 showed no detectable biological activity. Structure-activity relationship studies suggested that the β-methoxyasparagine moiety, ring C, or both, are important for antibacterial activity and DNA gyrase inhibition, whereas rings A and B present in compounds 4 and 5 appear to be dispensable. These findings provide valuable insights into the structural simplification of hexapeptidic coralmycins for the development of therapeutic agents against multidrug-resistant Gram-negative bacterial infections.

Related

  1. Transtibial Medial Meniscus Root Repair With Simplified Cross‐Bar Suture Configuration and Knotless Centralization
    Charles Qin, Neal Goldenberg, Gregory Leather
    Arthroscopy techniquesPeer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMC
  2. Driving pressure, simplified elastic mechanical power, and time to liberation from mechanical ventilation: a competing-risks and time-anchored observational study
    Xiaozhuang Pan, Shijia Chen, Xiyan Yu +1
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicineCrossref
  3. A simplified method for evaluating fine particulate matter removal performance of portable air cleaners
    Andrew B. Martin, Sumit Sankhyan, Rileigh L. Robertson +1
    MethodsXPeer-reviewedCC BY-NC-NDFull textPharmacology & toxicologyEurope PMCEurope PMCPMC
  4. Impact of ethanol on odor detection thresholds relevant to No- and Low-Alcohol (NoLo) wines: a combined sensory and computational approach in simplified static hydroalcoholic model wine
    Laura Brian, Anthony Santacreu, Come de Tournadre +6
    Current Research in Food SciencePeer-reviewedCC BY-NC-NDFull textGeneral biologyAnalytical chemistryHAL
  5. A simplified Fazekas scale for efficient assessment of white matter hyperintensities.
    Peng Liu, Songguo Liu, Chuanna Xu +6
    Frontiers in neurologyPeer-reviewedCC BYFull textNeurologyEurope PMCCrossref
BibTeX
@article{choi2026simplified,
  title = {{A New Simplified Coralmycin Derivative with Potent Anti-Gram-Negative Activity and Its Congeners Produced by the Myxobacterium Corallococcus coralloides M23.}},
  author = {Ha-Young Choi and Duc Dat Le and Bo-Min Kim and Won-Gon Kim},
  journal = {Journal of microbiology and biotechnology},
  year = {2026},
  month = oct,
  doi = {10.4014/jmb.2605.05042},
  url = {https://europepmc.org/article/MED/42894976},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - A New Simplified Coralmycin Derivative with Potent Anti-Gram-Negative Activity and Its Congeners Produced by the Myxobacterium Corallococcus coralloides M23.
AU  - Ha-Young Choi
AU  - Duc Dat Le
AU  - Bo-Min Kim
AU  - Won-Gon Kim
PY  - 2026
DA  - 2026/10/19
JO  - Journal of microbiology and biotechnology
DO  - 10.4014/jmb.2605.05042
UR  - https://europepmc.org/article/MED/42894976
AB  - Multidrug-resistant (MDR) Gram-negative bacterial infections urgently require new antibacterial agents with novel chemical scaffolds. In our continued investigation of minor metabolites produced by the myxobacterium Corallococcus coralloides M23, we isolated three new coralmycin derivatives, coralmycins J (1), K (2), and L (3), from large-scale fermentation cultures. Spectroscopic analyses revealed that these compounds represent structurally simplified derivatives of coralmycin with varying degrees of truncation. Compounds 1-4 (coralmycins J, K, L, and A) are new natural products isolated in our recent and current studies, while compound 5 (cystobactamid 919-2) is the externally reported reference compound used for comparison. Compound 1 exhibited potent antibacterial activity against both Gram-positive and Gram-negative bacteria and effectively inhibited E. coli DNA gyrase, whereas compounds 2 and 3 showed no detectable biological activity. Structure-activity relationship studies suggested that the β-methoxyasparagine moiety, ring C, or both, are important for antibacterial activity and DNA gyrase inhibition, whereas rings A and B present in compounds 4 and 5 appear to be dispensable. These findings provide valuable insights into the structural simplification of hexapeptidic coralmycins for the development of therapeutic agents against multidrug-resistant Gram-negative bacterial infections.
SN  - 1017-7825
SN  - 1738-8872
ER  -